|
Aytu BioPharma, Inc. (AYTU) Valoración de DCF
US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Aytu BioPharma, Inc. (AYTU) Bundle
¡Explore el potencial financiero AYTU BioPharma, Inc. (AYTU) con nuestra calculadora DCF fácil de usar! Ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de AYTU BioPharma, Inc. (AYTU) e informar sus decisiones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.6 | 65.6 | 96.7 | 107.4 | 81.0 | 108.1 | 144.3 | 192.5 | 256.9 | 342.9 |
| Revenue Growth, % | 0 | 137.52 | 47.29 | 11.1 | -24.58 | 33.45 | 33.45 | 33.45 | 33.45 | 33.45 |
| EBITDA | -12.2 | -29.0 | -28.0 | -3.5 | -1.0 | -26.3 | -35.2 | -46.9 | -62.6 | -83.6 |
| EBITDA, % | -44.18 | -44.25 | -28.92 | -3.27 | -1.25 | -24.37 | -24.37 | -24.37 | -24.37 | -24.37 |
| Depreciation | 4.6 | 7.7 | 10.1 | 8.8 | 8.3 | 12.4 | 16.5 | 22.0 | 29.4 | 39.3 |
| Depreciation, % | 16.61 | 11.73 | 10.5 | 8.21 | 10.21 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 |
| EBIT | -16.8 | -36.7 | -38.1 | -12.3 | -9.3 | -38.7 | -51.7 | -69.0 | -92.0 | -122.8 |
| EBIT, % | -60.79 | -55.98 | -39.42 | -11.48 | -11.46 | -35.82 | -35.82 | -35.82 | -35.82 | -35.82 |
| Total Cash | 48.1 | 49.6 | 19.4 | 23.0 | 20.0 | 52.3 | 69.8 | 93.1 | 124.2 | 165.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.6 | 28.2 | 21.7 | 28.9 | 23.6 | 30.7 | 40.9 | 54.6 | 72.9 | 97.3 |
| Account Receivables, % | 20.39 | 42.93 | 22.46 | 26.94 | 29.16 | 28.38 | 28.38 | 28.38 | 28.38 | 28.38 |
| Inventories | 10.0 | 16.3 | 10.8 | 12.0 | 12.6 | 21.4 | 28.6 | 38.1 | 50.9 | 67.9 |
| Inventories, % | 36.19 | 24.89 | 11.22 | 11.17 | 15.6 | 19.81 | 19.81 | 19.81 | 19.81 | 19.81 |
| Accounts Payable | 11.6 | 19.3 | 11.0 | 13.5 | 10.4 | 23.4 | 31.2 | 41.7 | 55.6 | 74.2 |
| Accounts Payable, % | 42.12 | 29.34 | 11.37 | 12.55 | 12.89 | 21.65 | 21.65 | 21.65 | 21.65 | 21.65 |
| Capital Expenditure | .0 | -2.3 | .0 | .0 | .0 | -.8 | -1.0 | -1.4 | -1.8 | -2.4 |
| Capital Expenditure, % | 0 | -3.57 | 0 | 0 | 0 | -0.71337 | -0.71337 | -0.71337 | -0.71337 | -0.71337 |
| Tax Rate, % | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 | -12.56 |
| EBITAT | -16.8 | -36.9 | -37.6 | -12.3 | -10.5 | -38.6 | -51.5 | -68.8 | -91.8 | -122.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.2 | -52.8 | -23.8 | -9.4 | -.5 | -29.9 | -45.6 | -60.9 | -81.3 | -108.5 |
| WACC, % | 22.28 | 22.28 | 22 | 22.28 | 22.28 | 22.22 | 22.22 | 22.22 | 22.22 | 22.22 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -164.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -111 | |||||||||
| Terminal Value | -547 | |||||||||
| Present Terminal Value | -201 | |||||||||
| Enterprise Value | -365 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | -360 | |||||||||
| Diluted Shares Outstanding, MM | 6 | |||||||||
| Equity Value Per Share | -65.06 |
What You Will Get
- Real Aytu BioPharma Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Aytu BioPharma, Inc. (AYTU).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit Aytu's specific needs.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Aytu BioPharma’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Aytu BioPharma, Inc. (AYTU).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Aytu BioPharma, Inc. (AYTU).
Key Features
- Real-Life AYTU Data: Pre-filled with Aytu BioPharma’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures to suit your analysis.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Create multiple forecast scenarios to explore various valuation outcomes.
- User-Friendly Design: Intuitive, structured layout designed for both professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file containing Aytu BioPharma, Inc.'s (AYTU) preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation results.
- 5. Present with Assurance: Deliver expert valuation insights to reinforce your strategic decisions.
Why Choose Aytu BioPharma Calculator?
- Accuracy: Reliable financial data from Aytu BioPharma ensures precise calculations.
- Flexibility: Tailored for users to easily modify and experiment with various inputs.
- Time-Saving: Eliminate the need to create a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive interface designed for users of all financial backgrounds.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest developments in biopharmaceuticals and their applications.
- Researchers: Utilize data-driven insights to support studies in drug efficacy and market trends.
- Investors: Evaluate investment opportunities and analyze valuation metrics for Aytu BioPharma, Inc. (AYTU).
- Pharmaceutical Analysts: Enhance your analysis with a comprehensive overview of Aytu's product pipeline.
- Entrepreneurs: Learn from Aytu's strategies in navigating the biopharmaceutical landscape.
What the Template Contains
- Historical Data: Includes Aytu BioPharma’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Aytu BioPharma’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Aytu BioPharma’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.